Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being

por Anand, Ernie, Berggren, Lovisa, Landry, John, Tóth, Ágoston, Detke, Holland C
Publicado 2016

A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendat...

por Anand, Ernie, Berggren, Lovisa, Deix, Claudia, Tóth, Ágoston, McDonnell, David P
Publicado 2015

Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis

por PAPP, Kim, PAUL, Carle, KLEYN, C. Elise, HUANG, Yu-Huei, TSAI, Tsen-Fang, SCHUSTER, Christopher, EL BAOU, Celine, TOTH, Agoston, RIEDL, Elisabeth, MROWIETZ, Ulrich
Publicado 2022